Atlas Trials

A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer

Clinical trial NCT01184287 · WITHDRAWN

Trial details

NCT number
NCT01184287
Sponsor
Tamir Biotechnology, Inc.
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.